196 related articles for article (PubMed ID: 10692002)
1. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes.
de Valk B; Addicks MA; Gosriwatana I; Lu S; Hider RC; Marx JJ
Eur J Clin Invest; 2000 Mar; 30(3):248-51. PubMed ID: 10692002
[TBL] [Abstract][Full Text] [Related]
2. Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry.
Jakeman A; Thompson T; McHattie J; Lehotay DC
Clin Biochem; 2001 Feb; 34(1):43-7. PubMed ID: 11239514
[TBL] [Abstract][Full Text] [Related]
3. Serum non-transferrin-bound iron and low-density lipoprotein oxidation in heterozygous hemochromatosis.
van Tits LJ; Jacobs EM; Swinkels DW; Lemmers HL; van der Vleuten GM; de Graaf J; Stalenhoef AF
Biochem Biophys Res Commun; 2006 Jun; 345(1):371-6. PubMed ID: 16682004
[TBL] [Abstract][Full Text] [Related]
4. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
5. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
Milman N; Fenger K; Graudal NA; Nielsen LS
Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
[TBL] [Abstract][Full Text] [Related]
6. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele.
Milman N
Eur J Haematol; 1991 Oct; 47(4):292-8. PubMed ID: 1954989
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes.
Adams PC
Am J Hematol; 1994 Feb; 45(2):146-9. PubMed ID: 8141120
[TBL] [Abstract][Full Text] [Related]
8. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
9. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
[TBL] [Abstract][Full Text] [Related]
10. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload.
McNamara L; MacPhail AP; Mandishona E; Bloom P; Paterson AC; Rouault TA; Gordeuk VR
J Gastroenterol Hepatol; 1999 Feb; 14(2):126-32. PubMed ID: 10029292
[TBL] [Abstract][Full Text] [Related]
11. Distinction between homozygous and heterozygous subjects with hereditary haemochromatosis using iron status markers and receiver operating characteristic (ROC) analysis.
Milman N; Albeck MJ
Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):95-8. PubMed ID: 7632826
[TBL] [Abstract][Full Text] [Related]
12. Biochemical expression of heterozygous hereditary hemochromatosis.
de Valk B ; Witlox RS; van der Schouw YT ; Marx JJ
Eur J Intern Med; 2000 Dec; 11(6):317-321. PubMed ID: 11113655
[TBL] [Abstract][Full Text] [Related]
13. Common presence of non-transferrin-bound iron among patients with type 2 diabetes.
Lee DH; Liu DY; Jacobs DR; Shin HR; Song K; Lee IK; Kim B; Hider RC
Diabetes Care; 2006 May; 29(5):1090-5. PubMed ID: 16644642
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
Bassett ML; Halliday JW; Ferris RA; Powell LW
Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
[TBL] [Abstract][Full Text] [Related]
15. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
O'Toole R; Romeril K; Bromhead C
Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068
[TBL] [Abstract][Full Text] [Related]
16. Transferrin saturation as a surrogate marker for assessment of labile nontransferrin bound iron in chronic liver disease.
Oliveira PMC; Espósito BP; Carvente C; Silva GA; Dellavance A; Baldo DC; Ferraz MLG
Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1047-1052. PubMed ID: 36052686
[TBL] [Abstract][Full Text] [Related]
17. HLA determinants in idiopathic haemochromatosis.
Milman N; Graudal N; Nielsen LS; Sørensen SA
Dan Med Bull; 1985 Oct; 32(5):262-4. PubMed ID: 4053696
[TBL] [Abstract][Full Text] [Related]
18. Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation.
van Tits LJ; Jacobs EM; Swinkels DW; Lemmers HL; van der Vleuten GM; de Graaf J; Stalenhoef AF
Atherosclerosis; 2007 Sep; 194(1):272-8. PubMed ID: 16963052
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.
Bulaj ZJ; Griffen LM; Jorde LB; Edwards CQ; Kushner JP
N Engl J Med; 1996 Dec; 335(24):1799-805. PubMed ID: 8943161
[TBL] [Abstract][Full Text] [Related]
20. Screening for iron overload in the Turkish population.
Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
